223 related articles for article (PubMed ID: 17660717)
1. Immune surveillance as a rationale for immunotherapy?
Pashov A; Monzavi-Karbassi B; Chow M; Cannon M; Kieber-Emmons T
Hum Vaccin; 2007; 3(5):224-8. PubMed ID: 17660717
[TBL] [Abstract][Full Text] [Related]
2. Immune surveillance and immunotherapy: lessons from carbohydrate mimotopes.
Pashov A; Monzavi-Karbassi B; Kieber-Emmons T
Vaccine; 2009 May; 27(25-26):3405-15. PubMed ID: 19200843
[TBL] [Abstract][Full Text] [Related]
3. [Oncoimmunology: some fundamental problems of cancer immunotherapy].
Nedospasov SA; Kuprash DV
Mol Biol (Mosk); 2007; 41(2):355-68. PubMed ID: 17514902
[TBL] [Abstract][Full Text] [Related]
4. Can calcium signaling be harnessed for cancer immunotherapy?
Rooke R
Biochim Biophys Acta; 2014 Oct; 1843(10):2334-40. PubMed ID: 24524821
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of malignant brain tumors.
Mitchell DA; Fecci PE; Sampson JH
Immunol Rev; 2008 Apr; 222():70-100. PubMed ID: 18363995
[TBL] [Abstract][Full Text] [Related]
6. Cancer vaccine development: on the way to break immune tolerance to malignant cells.
Mocellin S; Rossi CR; Nitti D
Exp Cell Res; 2004 Oct; 299(2):267-78. PubMed ID: 15350526
[TBL] [Abstract][Full Text] [Related]
7. Targeting the immune system in cancer.
Chaudhuri D; Suriano R; Mittelman A; Tiwari RK
Curr Pharm Biotechnol; 2009 Feb; 10(2):166-84. PubMed ID: 19199949
[TBL] [Abstract][Full Text] [Related]
8. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
Mapara MY; Sykes M
J Clin Oncol; 2004 Mar; 22(6):1136-51. PubMed ID: 15020616
[TBL] [Abstract][Full Text] [Related]
9. Reverse immunoediting: When immunity is edited by antigen.
Merlo A; Dalla Santa S; Dolcetti R; Zanovello P; Rosato A
Immunol Lett; 2016 Jul; 175():16-20. PubMed ID: 27131431
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic immunotherapy strategies for cancer: mechanisms and clinical development.
Aguilar LK; Guzik BW; Aguilar-Cordova E
J Cell Biochem; 2011 Aug; 112(8):1969-77. PubMed ID: 21465529
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
[TBL] [Abstract][Full Text] [Related]
12. Cytokines, tumour-cell death and immunogenicity: a question of choice.
Musiani P; Modesti A; Giovarelli M; Cavallo F; Colombo MP; Lollini PL; Forni G
Immunol Today; 1997 Jan; 18(1):32-6. PubMed ID: 9018972
[No Abstract] [Full Text] [Related]
13. Forcing tumor cells to present their own tumor antigens to the immune system: a necessary design for an efficient tumor immunotherapy.
Humphreys RE; Hillman GG; von Hofe E; Xu M
Cell Mol Immunol; 2004 Jun; 1(3):180-5. PubMed ID: 16219165
[TBL] [Abstract][Full Text] [Related]
14. Radiation Therapy and the In Situ Vaccination Approach.
Golden EB; Marciscano AE; Formenti SC
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):891-898. PubMed ID: 32800803
[TBL] [Abstract][Full Text] [Related]
15. A fresh look at tumor immunosurveillance and immunotherapy.
Smyth MJ; Godfrey DI; Trapani JA
Nat Immunol; 2001 Apr; 2(4):293-9. PubMed ID: 11276199
[TBL] [Abstract][Full Text] [Related]
16. Immune based therapies in cancer.
Krüger C; Greten TF; Korangy F
Histol Histopathol; 2007 Jun; 22(6):687-96. PubMed ID: 17357098
[TBL] [Abstract][Full Text] [Related]
17. Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: to use or not to use?
Strioga MM; Darinskas A; Pasukoniene V; Mlynska A; Ostapenko V; Schijns V
Vaccine; 2014 Jul; 32(32):4015-24. PubMed ID: 24837511
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor immunity and cellular cancer therapies].
Catros-Quemener V; Bouet F; Genetet N
Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
[TBL] [Abstract][Full Text] [Related]
19. Manipulation of Innate and Adaptive Immunity through Cancer Vaccines.
Sayour EJ; Mitchell DA
J Immunol Res; 2017; 2017():3145742. PubMed ID: 28265580
[TBL] [Abstract][Full Text] [Related]
20. Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated
Hernández-Luna MA; Luria-Pérez R
J Immunol Res; 2018; 2018():2984247. PubMed ID: 30302344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
